Cryptosporidium hominis and Cryptosporidium parvum Subtypes Identified From Patient Specimens in New York State
The Journal of Infectious Diseases · 16.11.2026 · 234 (5) · 687-696
DOI: 10.1093/infdis/jiag324 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 25.06.2026. Verfasst von Kimberly Mergen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Parasitology Laboratory, Wadsworth Center, NewYork State Department of Health, Albany, New York, USA. Hauptthemen laut MEDLINE: Cryptosporidiosis, Cryptosporidium parvum, Cryptosporidium. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Background
Cryptosporidium is a pathogenic intestinal parasite that causes cryptosporidiosis, a diarrheal disease common in the United States. The predominant species infecting humans are Cryptosporidium hominis and Cryptosporidium parvum. These species can be further classified into families and subtypes by analyzing the sequence of the 60-kDa glycoprotein (gp60) gene. Currently, there are no data available regarding the families and subtypes of Cryptosporidium found in New York State or their distribution within the state.
Methods
To address these unknowns, the gp60 gene was sequenced to identify the subtypes for C. hominis– and C. parvum–positive specimens submitted to the Wadsworth Center (the Public Health Laboratory for New York State ) in 2022 and 2023.
Results
In total, 634 specimens tested positive for C. hominis, and a subtype family was determined for 613. In 2022 and 2023 IdA16 and IfA12G1R5 were the most frequently identified C. hominis subtypes. Interestingly, IdA16 is typically not found in the United States, while subtype IfA12G1R5 is currently recognized as the dominant C. hominis subtype. For C. parvum, there were 489 positive specimens over the 2-year period, with a family and subtype identified for 466. Subtype family IIa was responsible for a majority of the infections. This family also had the greatest genetic diversity, with 30 subtypes identified throughout the surveillance period.
Conclusions
Laboratory surveillance data like those presented here aid in improving outbreak detection and investigations, determine the geographic distribution of subtypes, and identify populations that may be at higher risk for Cryptosporidium infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Parasitology Laboratory, Wadsworth Center, NewYork State Department of Health, Albany, New York, USA.
- Department of Environmental Health Sciences, College of Integrated Health Sciences, University at Albany, Albany, NewYork, USA.
- Bureau of Communicable Disease Control, NewYork State Department of Health, Albany, New York, USA.
ORCID-Profile: Susan Madison-Antenucci
Zitieren
APA
Mergen, K., Robbins, A., & Madison-Antenucci, S. (2026). Cryptosporidium hominis and Cryptosporidium parvum Subtypes Identified From Patient Specimens in New York State. The Journal of Infectious Diseases, 234(5), 687-696. https://doi.org/10.1093/infdis/jiag324
Vancouver
Mergen K, Robbins A, Madison-Antenucci S. Cryptosporidium hominis and Cryptosporidium parvum Subtypes Identified From Patient Specimens in New York State. The Journal of Infectious Diseases. 2026;234(5):687-696. doi:10.1093/infdis/jiag324
BibTeX
@article{Mergen2026,
author = {Mergen, Kimberly and Robbins, Amy and Madison-Antenucci, Susan},
title = {Cryptosporidium hominis and Cryptosporidium parvum Subtypes Identified From Patient Specimens in New York State},
journal = {The Journal of Infectious Diseases},
year = {2026},
volume = {234},
number = {5},
pages = {687--696},
doi = {10.1093/infdis/jiag324}
}
EUVIMED